Individuals with elevated levels of amyloid and tau proteins in the brain exhibited a cognitive decline rate three times faster than those with just one or no elevated biomarker levels, according to a study from the University of Wisconsin School of Medicine and Public Health. Amyloid and tau are measurable substances in the brain that are biological markers (or biomarkers for short) for Alzheimer’s disease.
The study, “Amyloid and tau imaging biomarkers explain cognitive...



